Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
January 2016 onwards
Submit An Event
Events - October 2012
Indian Lab Automation 2012
30 Oct 2012 - 31 Oct 2012 - Mumbai, India
This conference will amalgamate the cutting-edge techniques used by leading research institutes. With access to all three tracks, Drug Discovery & Development, Advances in Genomics & Informatics and Advances in Bioanalysis, this conference aims to provide delegates with a comprehensive overview of the essential techniques required to investigate current scientific advancements.
The Flow Chemistry workshop will be taking place prior to this conference.
Drug Discovery & Development
In the ever-expanding field of drug development it is vital for scientists to remain at the forefront of drug discovery and refinement in order to keep up with consumerist demand. With a need for improved specificity and fewer side-effects in patients, our speakers will be discussing the sophisticated details of the fundamental techniques required to develop the most successful drugs.
This branch of analytical chemistry is essential in obtaining accurate quantitative measurements of drug metabolites and macromolecules. Keynote presentations will talk about innovative analytical methods, explain their movement towards a more reliable, rational approach of analysis, and describe the considerable impact these techniques can have on the overall success of pharmaceutical research.
Advances in Genomics and Informatics
Despite the remarkable feat of sequencing the human genome nearly ten years ago, the sheer volume of information that DNA provides us with requires continual advancements in the way we unravel and analyse the data. Our speakers will address numerous methods of analysis, particularly focusing on the exciting areas of epigenetics, miRNA and Next-Gen Sequencing.
For more information on the stimulating research involved in epigenetics, miRNA and Next-Gen Sequencing, please view the information on the Genomics Research Asia conference being held later this year.
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,500+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!